Acutaas Chemicals balance sheet

As of Sep 2026

Total assets: ₹2,221cr+31.0% on Sep 2025
Shareholders' equity: ₹1,920cr+33.4% on Sep 2025
Total debt: ₹5.9cr+2,825.5% on Sep 2025
Cash and investments: ₹289cr+67.4% on Sep 2025

₹ crore except per share

Tap a line for its trend	H1 FY27Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	1,005	633	505	360	222
	66.9	332	130	125	25.5
	104	104	56.8	56.8	20.3
	6.1	7.2	8.3	10.3	16.9
	0.0	0.0	0.0	0.0	4.3
	0.2	0.2	0.2	0.2	1.7
	0.0	0.0	0.0	0.0	0.2
	8.1	8.2	4.9	2.6	6.2
	8.3	8.4	5.1	2.8	8.1
	4.8	0.0	0.0	0.0	—
	13.9	17.1	51.8	44.7	—
	1,209	1,103	758	600	297
	280	231	180	157	119
	358	363	290	206	230
	289	216	185	29.7	30.5
	18.1	9.3	63.7	23.6	28.1
	2.6	2.6	2.2	1.6	1.3
	59.9	59.9	70.1	0.0	—
	668	650	612	261	290
	64.0	—	0.0	75.4	57.4
	1,012	881	792	496	470
	2,221	1,984	1,549	1,096	767
Equity
	40.9	40.9	40.9	36.9	36.4
	1,817	1,613	1,269	637	558
	1,857	1,654	1,310	674	594
	62.9	57.2	10.5	8.8	—
	1,920	1,711	1,320	683	594
Liabilities
	0.0	0.0	0.0	114	0.6
	9.3	9.1	4.8	0.0	—
	9.3	9.1	4.8	114	0.6
	2.5	4.6	2.5	1.3	0.7
	35.4	28.7	19.6	13.0	8.8
	47.1	42.4	26.9	128	10.1
	5.9	26.5	8.2	103	3.0
	156	154	156	135	142
	162	180	164	238	145
	47.0	32.5	24.5	13.2	11.4
	0.0	5.5	0.0	0.0	—
	44.8	12.4	13.5	34.4	6.4
	253	231	202	285	163
	301	273	229	413	173
	2,221	1,984	1,549	1,096	767
Assets — additional as-filed lines
	0.0	0.0	0.0	2.5	3.2
Trade payables — MSME split
	14.5	27.2	54.3	—	—
	141	127	102	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

ACUTAAS₹3,976.70

Acutaas Chemicals Ltd.

· Pharma & Health

₹ CrorePeersANURAS AETHER BLUEJET CAPLIPOINT CONCORDBIO EMCURE JBCHEPHARM ERISMcap ₹32,558 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Non-current Assets
+ Property, Plant & Equipment	221.8	360.1	505.3	633.3	1,004.5
+ Capital Work-in-Progress	25.5	125.4	130.3	332.3	66.9
+ Goodwill	20.3	56.8	56.8	104.3	104.3
+ Other Intangibles	16.9	10.3	8.3	7.2	6.1
+ Intangibles under Development	4.3	0.0	0.0	0.0	0.0
+ Non-current Investments	1.7	0.2	0.2	0.2	0.2
+ Long-term Loans	0.2	0.0	0.0	0.0	0.0
+ Other Non-current Financial Assets	6.2	2.6	4.9	8.2	8.1
Non-current Financial Assets	8.1	2.8	5.1	8.4	8.3
+ Deferred Tax Assets	—	0.0	0.0	0.0	4.8
+ Other Non-current Assets	—	44.7	51.8	17.1	13.9
Total Non-current Assets	296.9	600.1	757.6	1,102.7	1,208.9
Current Assets
+ Inventories	119.2	156.7	179.9	231.3	280.3
+ Trade Receivables	230.3	206.4	290.5	362.6	358.3
+ Cash & Cash Equivalents	30.5	29.7	185.2	215.6	288.8
+ Other Bank Balances	28.1	23.6	63.7	9.3	18.1
+ Short-term Loans	1.3	1.6	2.2	2.6	2.6
+ Other Current Financial Assets	—	0.0	70.1	59.9	59.9
Current Financial Assets	290.3	261.2	611.7	649.9	667.8
+ Other Current Assets	57.4	75.4	0.0	—	64.0
Total Current Assets	470.1	495.8	791.6	881.3	1,012.0
Total Assets	766.9	1,095.9	1,549.3	1,984.0	2,220.9
Equity
+ Equity Share Capital	36.4	36.9	40.9	40.9	40.9
+ Other Equity / Reserves	557.5	637.1	1,268.7	1,612.6	1,816.5
Equity — Owners of Parent	594.0	674.0	1,309.6	1,653.6	1,857.4
+ Minority Interest	—	8.8	10.5	57.2	62.9
Total Equity	594.0	682.8	1,320.1	1,710.8	1,920.4
Liabilities
+ Borrowings — Non-current	0.6	113.6	0.0	0.0	0.0
+ Other Non-current Financial Liab	—	0.0	4.8	9.1	9.3
Non-current Financial Liabilities	0.6	113.6	4.8	9.1	9.3
+ Provisions — Non-current	0.7	1.3	2.5	4.6	2.5
+ Deferred Tax Liabilities	8.8	13.0	19.6	28.7	35.4
Non-current Liabilities	10.1	128.0	26.9	42.4	47.1
+ Borrowings — Current	3.0	103.0	8.2	26.5	5.9
+ Trade Payables	142.0	134.6	156.0	153.9	155.8
Current Financial Liabilities	145.0	237.6	164.2	180.4	161.6
+ Provisions — Current	11.4	13.2	24.5	32.5	47.0
+ Current Tax Liabilities	—	0.0	0.0	5.5	0.0
+ Other Current Liabilities	6.4	34.4	13.5	12.4	44.8
Current Liabilities	162.8	285.2	202.2	230.8	253.4
Total Liabilities	173.0	413.1	229.2	273.2	300.5
Total Equity & Liabilities	766.9	1,095.9	1,549.3	1,984.0	2,220.9
Assets — additional as-filed lines
+ Current Tax Assets	3.2	2.5	0.0	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	54.3	27.2	14.5
+ Dues to Other Creditors — Current	—	—	101.7	126.7	141.3

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.